Published: August 9th, 2022,
Last updated: August 9th, 2022
The French pharmaceutical company Sanofi has made a €300 million investment in the Chinese biotech company Innovent Biologics. The two companies plan to jointly develop two cancer drugs in China, as reported by the business portal Caixin. According to company sources, Innovent has signed a licensing agreement with Sanofi for the exclusive marketing of the drugs.